Contact this trialFirst, we need to learn more about you.
Monoclonal Antibodies
Durvalumab + Chemoradiation for Non-Small Cell Lung Cancer
Recruiting2 awardsPhase 3
Elk Grove Village, Illinois
This trial is testing whether adding durvalumab to standard chemoradiation followed by additional durvalumab can extend patients life and/or prevent the tumor from coming back compared to the usual approach of chemoradiation alone followed by durvalumab.
Fill-in a few details and create your profileHaving a profile will help us send you recommended trials and speed up your application in the future.
We will keep your details privateWe won’t share unless you give us permission. By completing this form you agree to our privacy policy
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.